We have evaluated thirty patients with malignant metastatic phaeochromocytoma with regard to clinical features, indices of catecholamine secretion, histology of lesions and a number of imaging procedures including scintigraphy with the recently developed sympathetic tissue-seeking radiopharmaceutical '3'I-metaiodobenzylguanidine (I3'I-MIBG). The primary tumour was extraadrenal in 13 cases. The commonest site of metastases was the axial skeleton (20 cases), followed by liver (four cases), lymph nodes (four cases), peritoneum (two cases) and lung (three cases). The malignancies were indolent, the mean time following the initial diagnosis was 9.18 years (range 0 to 33 years) and the mean duration of known metastases 3.7 1 years (range 0 to 18 years). There was a wide range of abnormalities in plasma and urinary catecholamines which did not correlate with the extent of tumour spread, histological pattern (mitotic index, Zellballen pattern, capsular or vascular invasion pleomorphism or necrosis) or I3II-MIBG uptake by tumour deposits. I3'I-MIBG scintigraphy was found to be a useful technique for determining the extent of metastatic disease in most cases (26 of 30) and in some patients (1 6 of 30) was more sensitive than other radiological procedures. No false positive scans were encountered.
B. Sliapiro et
; Palmieri e t a Mahoney & Harrison, 1977) . However, the definition of malignancy for this tumour is difficult for it cannot be defined on histological criteria alone (Symington & Goodall, 1953) . The most rigorous definition of malignancy is that which requires that metastases should be present at a site where chromaffin tissue is not otherwise found, thus excluding the possibility of misclassifying multifocal primary lesions as metastases. The prognosis from a variety of reports of malignant phaeochromocytomas appears highly variable (Palmieri e f d., James et al., 1972; Mahoney & Harrison, 1977; Modlin et al., 1979) .
We used "'I-metaiodobenzylguanidine (Ij'I-MIBG) to portray the scintigraphic features of 30 patients having malignant phaeochromocytoma. The recently developed radiopharmaceutical, '"I-MIBG, structurally resembles noradrenaline and is taken up by phaeochromocytomas, by a mechanism believed to be similar to that by which noradrenaline is taken up following secretion (Wieland et d., 1980 (Wieland et d., , 1981 Sisson el al., 1981) . Thus, I3'I-MIBG scintigraphy reflects an anatomical localization of a function specific to adrenergic tumours and therefore a new index of the nature and growth ofphaeochrornocytom as.
MATERIALS A N D METHODS
The histological specimens of 20 of the 30 patients were reviewed. This included material from primary and in some cases metastatic tumours. Light microscopy was performed on haemotoxylin and eosin stained sections and in certain cases on Grimelius silver stained sections.
The plasma concentrations of norepinephrine, epinephrine and dopamine were determined in the fasted, supine and resting state by radioenzymatic assay (Peuler & Johnson, 1977) . The overnight (1 2-hour) urinary excretion of catecholamines and their metabolites was determined by the technique of Von Euler and Lishajko (1959) .
'3'I-metaiodobenzylguanidine scintigraphy was performed by previously described techniques. The dose of 0.5 mCi was administered by intravenous injection over 10-20 S. The thyroidal uptake of the dissociated I3'I-iodide was prevented by the administration of iodides. Multiple overlapping images including anterior and posterior views of the head, thorax, abdomen, pelvis and upper femoral regions were obtained (Sisson el a/., 1981) . Anatomical orientation was provided by surface markers and in selected cases by scintigraphic visualization of other organs such as kidney (99mTc-DTPA), liver and spleen (99mTc-sulphur colloid), skeleton (99mTc-methylene diphosphonate (MDP), or heart (20'T1 or 99mTc-labelled red blood cells (RBCs). Digitized I3'I-MIBG and orientation scans were superimposed by computer (Shapiro et at., 1982a) . A number of different modalities were used in various combinations to delineate the patients' lesions. They included standard radiographs, intravenous pyelography, ultrasound, computed tomography (CT), and arteriography in various combinations in different patients (see Table I ).
A total of thirty patients fulfilled the criteria for the diagnosis of malignant phaeochromocytoma (Palmieri etal., 1961) . These patients were amongst the 270patients referred to the University of Michigan Medical Center for '3'I-metaiodobenzylguanidine (I3'I-MIBG) scintigraphy for known or suspected phaeochromocytomas between June 1980 and January 1983.
RESULTS

Morphology
In general, the light microscopic features of the tumours included a very vascular stroma with solid sheets of cells and a zellballen pattern. Hyaline droplets were frequently observed in the cytoplasm of most intra-adrenal tumours. Pleomorphism, mitotic figures, vascular and capsular invasion, and necrosis were frequently present; these features while not specific for malignancy occurred more frequently than in phaeochromocytomas that have classically been defined as benign. In most cases, the histologies of primary and metastatic lesions were similar; however, in two patients with skeletal metastases, the metastatic foci consisted of poorly differentiated spindle cells different from the primary neoplasm.
The histological features, and especially the invasive character, did not correlate with the anatomic extent of tumour spread. Moreover, the morphologies did not predict the uptake of I3'I-MIBG on scintigraphy, or the hormone secretion determined by plasma catecholamine concentrations or urinary catecholamine excretion rates.
Demographic features
The majority of patients were male (21 of 30), the mean age at diagnosis was 32.0 years (range 10-57 years) with 11 of 30 occurring under the age of 18 years. The malignancies were indolent: mean duration following the initial diagnosis of phaeochromocytoma was 9-18 years (range 0-33 years), while the mean duration of known metastases was 3.71 years (range 0-1 8 years).
Two of the patients studied had definite historical, clinical or biochemical evidence for one of the neurocristopathic syndromes known to be associated with phaeochromocytoma, having Von Recklinghausen's neurofibromatosis and Von Hipple-Lindau's disease (Riccardi, 198 1). Another had possible Von Hippel-Lindau's syndrome. Neurocristopathies not encountered were multiple endocrine neoplasia type 2A or 2B (Lorenzo, 1977; Sizemore et al., 1980) . Two o f the patients, however, gave a family history of phaeochromocytoma and one had a sister with 'nonfunctioning' paraganglioma resected; another case whose primary lesion arose from the bladder, gave the remarkable history of a mother who had two phaeochromocytomas resected from the pelvis and bladder as a teenager.
B. Slmpiro et al.
In 13 of 30 cases the primary lesion was extra-adrenal (four para-renal, two bladder, two para-aortic, and one para-adrenal. pancreatic, left atrial, abdominal sympathetic chain and widespread).
Fur I c, t iot i d in dices Holmone secretioiz
Each patient had evidence for abnormally elevated secretion of catecholamines, but plasma noradrenaline concentrations varied widely from minimally abnormal (456 pg.'ml) to markedly elevated (54253 pg:ml), the upper limit of normal being 350 pg/ml. Plasma adrenaline concentrations were elevated in 18 of 30 cases to as high as 2834 pg/ml (upper limit of normal 100 pg;ml). The urinary excretion rates of catecholamines and catecholamine metabolites were also variable and did not always correlate well with the plasma catecholamine concentrations. However, at least one fraction of the urinaryexcretion rates was abnormal in every case. The excretion rates of noradrenaline (range 35-10670 pg/12 h; normal<60 p g , 12 h) and VMA (range 2 3 to 56.5 mg/12 h, normal < 3.5 mg,'12 h) had the highest diagnostic significance, each being elevated in all but two cases.
A particularly unusual pattern of excretion was observed in one patient who demonstrated normal or borderline levels for plasma catecholamine concentrations and for the urinary adrenaline. noradrenaline. metanephrine and VMA excretion rates, but in sharp contrast. his plasma concentration (9200 pgiml, normal < 144 pg/ml) and excretion rate of normetanephrine (2664 p g ; 12 h, normal < 82.5 pg/ 12 h) were strikingly elevated. Although plasma dopamine concentrations were not measured in every case, there was no evidence that malignancy caused reversion to a more primitive type of secretion pattern in these phaeochromocytomas. Dopamine values were normal or near normal in each of the 10 instances where measured.
13' I-MIBG uptnke nndnnntoniic spread oj'tuniour
The extent of tumour dissemination was determined by i"I-MIBG scintigraphy and other medical imaging procedures and in some cases surgical exploration and the results are summarized in Table 1 ; representative examples are shown in Figs 1 to 4.
Skeletal metastases were present in 20 cases. I3'I-MIBG scintigraphy revealed skeletal metastases in 19 of 30 cases. In 12 cases. 99mTc-MDP bone scans were performed; in six of these patients I"I-MIBG scintigraphy was more sensitive in establishing the extent of skeletal metastases (six patients) but in six cases the reverse was true. However, I3'I-MIBG uptake may have been diminished by previous external beam irradiation directed at the skeletal metastases in four instances. Lesions occurred principally in the axial skeleton and varied from involvement of a single vertebral lesion to widespread dissemination, see Figs 1 , 2 and 3.
Hepatic metastases were present in four of 30 patients and concentrated "'I-MIBG to a moderate extent in three but not at all in one patient in whom CT and biopsy confirmed the lesions (see Fig. 3 ). Splenic involvement was observed in only one case. Primary tumours and tumours recurrent at the primary site also exhibited variable I3lI-MIBG uptake: from excellent to barely detectable (Figs 1 and 4) . Regional lymph node metastases were visualized in four patients but not in another in whom the deposits were microscopic and discovered only by histological study of nodes removed at operation. Widespread pulmonary metastases were well demonstrated by I3'I-MIBG (Fig. 4 ) scintigraphy in two patients but only faintly in another where they were known to be present. Neither I3'I-MIBG scintigraphy, which detected larger peritoneal tumour deposits, nor CT, demonstrated small peritoneal seedlings in a patient which were only revealed at laparotomy.
The clinical features of phaeochromocytoma at the time of original diagnosis and of '"I-MIBG scintigraphy showed no correlation with the extent of tumour spread (Table  2) . At the time of I3'I-MIBG scintigraphy all but three patients were receiving therapy, mostly adrenergic receptor blocking agents, for control of hormone-provoked symptoms. These medications ameloriated symptoms in most cases (Table 2 ), but did not appear to influence the uptake of 13'I-MIBG by tumour. Symptoms arose principally from the effects of catecholamine excess or to a lesser extent local tumour masses.
DISCUSSION Morphology
Each of our 30 patients fulfilled the criteria for malignancy. Although no histological criteria are totally specific for malignancy, features such as mitotic figures, pleomorphism, necrosis and capsular or vascular invasion occurred frequently in the cases studied and we have found some of these features including necrosis, mitoses and vascular invasion, to be rare in phaeochromocytomas which follow a benigh course. N o histological feature predicted the anatomical extent of tumour spread, 'I'I-MIBG uptake nor patterns ofplasma catecholamine concentrations or urinary catecholamine excretion rates. A zellballen pattern was more prominent in the extra-adrenal tumours than in the intra-adrenal phaeochromocytomas.
Demogrupliic features
The Scott et a/., 1982) or female preponderance in others (Wust Van et al., 1964; Sander et al., 1971; Mahoney & Harrison, 1977) . Reports of paediatric patients also describe a higher frequency in females (Quissel et al., 1979) .
In only two of our patients was there unequivocal evidence of a neurocristopathic syndrome known to be associated with phaeochromocytoma (Quissel et ai., 1979; Sizemore et al., 1980; Riccardi, 198 I) . This reflects the small percentage of phaeochromocytomas due to these syndromes as well as the rarity of malignant change in adrenergic tumours of the familial type.
Since the vast majority of phaeochromocytomas arise from one or both adrenal glands, our finding that 13 of 30 malignant tumours arose in extra-adrenal sites confirms the observation that extra-adrenal phaeochromocytomas are more likely to be malignant (Schonebe, 1969; Glenn & Gray, 1976; Shapiro et a/., 1982a) . This observation held for tumours arising in both adults and children (Lorenzo, 1977; Quissel et al., 1979) .
Functional indices N o n u t echolamine humoral efects
Phaeochromocytomas have been associated with a number of para-neoplastic syndromes not explicable on the basis of elevated catecholamine levels. These include polycythaemia, hyperthermia and hypercalcaemia in the absence of hyperparathyroidism (Symington & Goodall, 1953; Waldmann & Bradley, 1961; Sjoerdsma et al., 1966; Shimbu & Makamo, 1974) . True polycythaemia with increased red cell mass appears to have been a result ofan erythropoietic-stimulating factor produced by the tumour (Waldmann & Bradley, 1961) and may resolve following extirpation. This condition must be distinguished from the apparent polycythaemia due to a contraction of plasma volume (in the absence of an expanded red cell mass) that may occur in untreated phaeochromocytoma (Sjoerdsma et al., 1966) and from coincidental polycythaemia Vera or secondary polycythaemia. One patient exhibited polycythaemia induced by the synthesis of erythropoietin by his malignant phaeochromocytoma with a markedly elevated haematocrit, a proportionally increased red cell mass, no evidence of leukocytosis or thrombocytosis, neither an abnormal haemoglobin nor hypoxia, and high levels of circulating immunoreactive erythropoietin. Urfortunately, due to the wide dissemination of his turnour, the phenomenon of regression following extirpation could not be demonstrated.
Abnormalities of catecholamines
Under normal circumstances, the conversion of noradrenaline to adrenaline requires the enzyme phenylethanolamine-n-methyltransferase and very high levels of cortisol, a combination present only in the adrenal medulla (Axelrod, 1962) . It is possible that in the face of very high noradrenaline concentrations a small amount of conversion to adrenaline may occur via extra-adrenal phenylethanolamine-n-methyltransferases (Buu et al., 1981; Kopp et al., 1978; Von Euler et al., 1961) . The same principle could hold for the tumours themselves. The elevated levels of adrenaline were not artefacts as they were substantiated by the assay of serial dilutions. However, whatever the source, patients did not exhibit adrenaline-type symptoms, all hormonally mediated symptoms and signs could be attributed to noradrenaline alone (with the exception of erythropoietin in one patient and hypercalcaemia in two others). The effects of malignant phaeochromocytoma are then the consequences of the local effects of tumour masses and/or of the elevated levels of circulating noradrenaline. Considerable variation in excretion patterns of the catecholamines and the catecholamine metabolites was observed, and these patterns were sometimes discrepant with plasma catecholamine concentrations reflecting differing rates of metabolism for the hormones. Thus, despite the experience of others who have found superior diagnostic precision with either technique alone (Crout et al., 1961; Sjoerdsma et a/., 1966; Bravo et af., 1979) , we advise the measurement of all components of plasma and urine.
I3'I-MIBG uptake
The mechanism of I3lI-MIBG uptake into adrenergic tissues (including malignant phaeochromocytoma) is believed to involve the active transport of I3'I-MIBG via the noradrenaline 're-uptake' mechanism (Sisson el al., 198 1; Wieland el al., 1980, 198 1) . The efficiency of this mechanism and hence the storage of l3'I-MIBG in vesicles need not necessarily parallel that of catecholamine synthesis, and indeed the wide spectrum of scintigraphic intensity by different lesions supports this concept. However, the reasons for the disparity of uptakes of I3'I-MIBG by the tumours of different patients and by different lesions within the same patient are at present unknown. However, in four patients major sites of skeletal metastases had been subjected to external beam irradiation before I3lI-MIBG scintigraphy and showed slight to no uptake. Such therapy may have affected the ability of the lesions to take up I3II-MIBG without halting catecholamine synthesis or causing tumour regression.
Since scintigraphy can usually demonstrate primary malignant phaeochromocytomas, recurrent tumours and most metastases, the imaging technique not only helps to define the extent of dissemination of known malignant disease, but also detects the malignant nature of what otherwise may be thought to be a benign phaeochromocytoma (4 of 30 in this series). Scintigraphy has the advantage of providing a noninvasive procedure that readily screens the whole body, and in many cases (16 of 30), it is more sensitive for phaeochromocytoma than CT, conventional radiography of bone scan. Focal uptake of "'I-MIBG has been specific for phaeochromocytoma (one false positive in 270 cascs studied, this being a patient with a large retroperitoneal neuroendocrine tumour which concentrated '?'I-MIBG but manifested no evidence of catecholamine hypersecretion), but the false negative rate has been about 7-10", (Shapiro e f al., 1982a, b) .
Anatomical .spread of' tuniotrr
The extent and pattern of spread of the principle lesions in the present series is typical, with the skeleton, liver, regional lymph nodes, lung and peritoneum affected in that order of frequency (Palmieri et al., 196 1 ; Wust Van et al., 1964; McCarthy et al., 1977; Quissel et a/., 1979 ) (see Table 1 ). Other rarer sites of spread such as brain (Ferrari et al., 1979) , skin (Cato er a/., 1967), pleura (Traub & Rosenfeld, 1970) and distant lymph nodes (Sandritter & Lasch, 1967) were not observed. The finding of skeletal metastases in 20 of 30 cases was in keeping with other series which have reported bone to be the commonest site for metastases (Schonebe, 1969; McCarthy et a/., 1977) and occasionally the only side (Stackpole et a/., 1973; McCarthy et al., 1977) . In many cases skeletal metastases showed high I3'I-MIBG uptake.
Four of 20 patients had liver deposits, another frequently recorded site of metastasis While hepatic uptake of "'I-MIBG is a normal finding in scintigraphy, the radiopharmaceutical disappears from this organ for the most part in 48 h. The relatively poor uptake of the tracer by hepatic metastases when compared to that seen in skeletal metastases is not due to the relatively high liver background but may reflect the influence of the host tissue on "'I-MIBG uptake by the tumour.
Clinical c0iir.w and therapy
Others authors have recorded varying courses for malignant phaeochromocytoma with survival varying from months to decades (Palmieri et James et Mahoney & Harrison, 1977; Modlin et al., 1979; Das & Lowe, 1980) . At present, 27 of the 30 patients are alive and 24 are fully functional although two patients have spinal cord compression with neurological deficits. Prolonged survival (up to decades) with widely mctastatic phaeochromocytoma is not uncommon (Traub & Kosenfeld, 1970; James et a/., 1972; Scharf et uf., 1973; VandenBroek & DeGraeff, 1978; Scott et al., 1982) , but our study population appears to have a disproportionate number of such cases. No obvious differences in the clinical presentations distinguish patients with the slowly and the rapidly progressive diseases (Mahoney & Harrison, 1977) . Pathological fractures were seen in slowly advancing tumours as well as with rapidly progressive and fatal disease. Many patients with pulmonary metastases survive only a year or two (VandenBroek & DeGraeff, 1978; Abemayor et al., 1980) a course borne by one patient in this series, but exceptions occur (VandenBroek & DeGraeff, 1978; Quissel et Abemayor et af., 1980) . The treatment of malignant phaeochromocytoma is unsatisfactory. The most impor-tant component is the use of blocking agents which block the effects of secretory products from the tumour (Boreus et al., 1968) . Such therapy, while not affecting tumour progression, may prevent life-threatening cardiovascular effects and permit prolonged survival and good quality of life despite widely disseminated tumours (Boreus et al., 1968; Scharf et al., 1973) . Catecholamine synthesis may be diminished by the administration of alphamethylparatyrosine. This drug seldom reduces catecholamines to completely normal levels, but may provide adequate control of hormonal effects when used alone or it may permit the reduction in the dose of adrenergic blocking agents (Sjoerdsma et al., 1965; Tchergakoff et al., 1972) . Locally invasive tumours may be cured by radical extirpation (Schonebe, 1969; Mahoney & Harrison, 1977; Drasin, 1978; Modlin et al., 1979; Das & Lowe, 1980) . Many patients may have long disease free intervals (up to decades) following initial surgery. Even when distant metastases have occurred, surgical excision of isolated lesions has been of benefit because of the reduction in catecholamine levels and removal of mass effects of lesions (McCarthy et al., 1977; VandenBroek & DeGraeff, 1978; Abemayor et al., 1980) . Multiple resections may be required (VandenBroek & DeGraeff, 1978) . Skeletal lesions may benefit from external beam irradiation while other sites are less responsive (James et Drasin, 1978) . The role of chemotherapy is debatable but responses to doxorubicin and cyclophosphamide have been reported (Joseph, 1967; Drasin, 1978) . All studies on the effects of irradiation and/or chemotherapy are hindered by the rarity and the variability in the natural history of this disease.
The affinity of the radiopharmaceutical, I3'I-MIBG, for many malignant phaeochromocytomas raises the possibility that benefit may occur from the administration of large doses of the radiopharmaceutical, a study now underway (Sisson et a/., 1983) .
